When the $3.4 billion deal to acquire the Eckerd and Brooks pharmacies is completed, the combined company will have more than 5,000 stores and nearly $27 billion in sales. It will also be closer in scale to rivals Walgreen and CVS. But the marriage of two turnarounds-in-progress won't work unless Sammons can improve store performance.